By Wendell Roelf and Julie Steenhuysen CAPE TOWN/CHICAGO (Reuters) - Moderna Inc has applied for patents in South Africa relating to its COVID-19 vacc.
Moderna Inc has applied for patents in South Africa relating to its Covid-19 vaccine, prompting fears the company could eventually seek to prevent a new African vaccine manufacturing hub from making its own version of the mRNA shot. Moderna spokesperson Colleen Hussey confirmed it had filed for patents "related to both the Covid-19 vaccine and Moderna's platform technology" in South Africa and elsewhere, after a group of 60 Africa-based charities raised concerns about them, but said the move would not block vaccine distribution in Africa.
By Wendell Roelf and Julie Steenhuysen CAPE TOWN/CHICAGO (Reuters) - Moderna Inc has applied for patents in South Africa relating to its COVID-19 vacc.